Heron Therapeutics (HRTX)

Earnings in 2024 (TTM): -€25.59 Million

According to Heron Therapeutics's latest financial reports the company's current earnings are €0.13 Billion. In 2023 the company made an earning of -€0.11 Billion, an increase over its 2022 earnings that were of -€0.17 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Heron Therapeutics from 1987 to 2024

Annual earnings

Year	Earnings	Change
2024 (TTM)	-€25.59 Million	-74.82%
2023	-€0.11 Billion	-39.26%
2022	-€0.17 Billion	-17.52%
2021	-€0.21 Billion	-2.9%
2020	-€0.21 Billion	11%
2019	-€0.19 Billion	14.49%
2018	-€0.17 Billion	-9.44%
2017	-€0.19 Billion	14.06%
2016	-€0.16 Billion	77.42%
2015	-€89.68 Million	27.79%
2014	-€70.18 Million	38.14%
2013	-€50.8 Million	126.29%
2012	-€22.45 Million	114.52%
2011	-€10.47 Million	14.64%
2010	-€9.13 Million	-2.92%
2009	-€9.41 Million	-55.6%
2008	-€21.18 Million	2.46%
2007	-€20.67 Million	19.23%
2006	-€17.34 Million	122.61%
2005	-€7.79 Million	-9.04%
2004	-€8.57 Million	40.92%
2003	-€6.08 Million	48.97%
2002	-€4.08 Million	-23.18%
2001	-€5.31 Million	29.01%
2000	-€4.12 Million	-345.99%
1999	€1.67 M	-24.15%
1998	€2.2 M	-1300%
1997	-€0.19 Million	-97.14%
1996	-€6.44 Million	-16.67%
1995	-€7.72 Million	-9.68%
1994	-€8.55 Million	-12.26%
1993	-€9.75 Million	65.63%
1992	-€5.89 Million	60%
1991	-€3.68 Million	-13.04%
1990	-€4.23 Million	53.33%
1989	-€2.76 Million	-49.15%
1988	-€5.43 Million	43.9%
1987	-€3.77 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Alkermes ALKS	€0.42 B	-1,767.42%	🇮🇪 Ireland
Pacira Biosciences PCRX	-€50.46 Million	96.35%	🇺🇸 USA
Nektar Therapeutics NKTR	-€0.16 Billion	501.82%	🇺🇸 USA
Ligand Pharmaceuticals LGND	€56.14 M	-318.46%	🇺🇸 USA
SurModics SRDX	-€5.7 Million	-77.83%	🇺🇸 USA

Earnings for Heron Therapeutics (HRTX)

Earnings in 2024 (TTM): -€25.59 Million

Earnings history for Heron Therapeutics from 1987 to 2024

Annual earnings

Earnings for similar companies or competitors

What is the market capitalization of a company?

DISCLAIMER

Contact

Links